Invention Grant
- Patent Title: Multimodal fusion for diagnosis, prognosis, and therapeutic response prediction
-
Application No.: US17762125Application Date: 2020-09-28
-
Publication No.: US12230399B2Publication Date: 2025-02-18
- Inventor: Faisal Mahmood , Richard Chen
- Applicant: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
- Applicant Address: US MA Boston
- Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
- Current Assignee: THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
- Current Assignee Address: US MA Boston
- Agency: Tarolli, Sundheim, Covell & Tummino LLP
- International Application: PCT/US2020/053079 WO 20200928
- International Announcement: WO2021/062366 WO 20210401
- Main IPC: G16H50/20
- IPC: G16H50/20 ; G06T7/00 ; G06V10/80 ; G06V20/69 ; G16B30/00 ; G16B40/20

Abstract:
Systems and methods can quantify the tumor microenvironment for diagnosis, prognosis and therapeutic response prediction by fusing different data types (e.g., morphological information from histology and molecular information from omics) using an algorithm that harnesses deep learning. The algorithm employs tensor fusion to provide end-to-end multimodal fusion to model the pairwise interactions of features across multiple modalities (e.g., histology and molecular features) and deep learning. The systems and methods improve upon traditional methods for quantifying the tumor microenvironment that rely on concatenation of extracted features.
Public/Granted literature
- US20220367053A1 MULTIMODAL FUSION FOR DIAGNOSIS, PROGNOSIS, AND THERAPEUTIC RESPONSE PREDICTION Public/Granted day:2022-11-17
Information query